Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Operating Expenses (2021 - 2026)

HeartSciences (HSCS) has disclosed Operating Expenses for 5 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 4.52% year-over-year to $2.1 million, compared with a TTM value of $8.2 million through Oct 2025, up 10.28%, and an annual FY2025 reading of $8.4 million, up 32.24% over the prior year.
  • Operating Expenses was $2.1 million for Q4 2025 at HeartSciences, up from $1.9 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $2.4 million in Q1 2025 and bottomed at $676174.0 in Q3 2021.
  • Average Operating Expenses over 5 years is $1.6 million, with a median of $1.7 million recorded in 2022.
  • The sharpest move saw Operating Expenses soared 111.67% in 2022, then fell 19.29% in 2023.
  • Year by year, Operating Expenses stood at $956856.0 in 2021, then skyrocketed by 85.49% to $1.8 million in 2022, then decreased by 11.41% to $1.6 million in 2023, then increased by 26.25% to $2.0 million in 2024, then rose by 4.52% to $2.1 million in 2025.
  • Business Quant data shows Operating Expenses for HSCS at $2.1 million in Q4 2025, $1.9 million in Q3 2025, and $1.9 million in Q2 2025.